Evidence map›Paper›PMID 22051336›Full record

ArticleJournal of the American College of Cardiology2011

Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function.

Bo Dai, Wei Huang, Meifeng Xu, Ronald W Millard, Mei Hua Gao, H Kirk Hammond, Donald R Menick, Muhammad Ashraf, Yigang Wang

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 63 citations in OpenAlex.

  1. Region- and Cell-type-Resolved Multiomic Atlas of the Heart.Molecular & cellular proteomics : MCP · 2025
    Article
  2. Direct Cardiac Reprogramming in the Age of Computational Biology.Journal of cardiovascular development and disease · 2024
    Review
  3. Article
  4. Review
  5. Review
  6. Induced pluripotent stem cell-based therapies for organ fibrosis.Frontiers in bioengineering and biotechnology · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Cardiovascular Bio-Engineering: Current State of the Art.Journal of cardiovascular translational research · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Bo DaiLiuhua Qiao Hospital, Guangzhou, Guangdong, China.
Wei Huang
Meifeng Xu
Ronald W Millard
Mei Hua Gao
H Kirk Hammond
Donald R Menick
Muhammad Ashraf
Yigang Wang
University of Cincinnati · USUniversity of California San Diego · US421 Hospital of PLA · CNMedical University of South Carolina · US

Funding

Stem Cells in Cardiac Repair and AngiogenesisR37HL074272 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ASHRAF, MUHAMMAD · 2003 to 2013
$5.7M
iPS cells-derived progenitor cells for angiomyogenesisR01HL110740 · NHLBI · UNIVERSITY OF CINCINNATI · PI ASHRAF, MUHAMMAD, WANG, YIGANG · 2011 to 2015
$2.9M
Mechanisms of Adenylyl Cyclase Effects in the HeartR01HL081741 · NHLBI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI HAMMOND, H. KIRK · 2005 to 2013
$2.8M
Mechanistic basis of myoblast therapy &angiomyogenesisR01HL080686 · NHLBI · UNIVERSITY OF CINCINNATI · PI ASHRAF, MUHAMMAD · 2005 to 2009
$2.7M
Stem Cell TherapyR01HL089824 · NHLBI · UNIVERSITY OF CINCINNATI · PI WANG, YIGANG · 2008 to 2012
$1.9M
Wnt11 signaling in stem cell survival and cardiac regenerationR01HL105176 · NHLBI · UNIVERSITY OF CINCINNATI · PI ASHRAF, MUHAMMAD, JONES, WALTER KEITH · 2010 to 2014
$1.9M
Lineage Specific Stem Cell Mobilization for Heart RepairR01HL081859 · NHLBI · UNIVERSITY OF CINCINNATI · PI WANG, YIGANG · 2005 to 2009
$1.9M
Mobilized Stem Cells in Cardiomyogenesis & AngiogenesisR01HL083236 · NHLBI · UNIVERSITY OF CINCINNATI · PI XU, MEIFENG · 2006 to 2010
$1.8M
NHLBI NIH HHS HL-080686NHLBI NIH HHS HL081859NHLBI NIH HHS HL089824NHLBI NIH HHS HL110740NHLBI NIH HHS R01 HL080686NHLBI NIH HHS R01 HL081741NHLBI NIH HHS R01 HL081859NHLBI NIH HHS R01 HL083236NHLBI NIH HHS R01 HL089824NHLBI NIH HHS R01 HL105176NHLBI NIH HHS R01 HL110740NHLBI NIH HHS R37 HL074272NHLBI NIH HHS R37HL-074272
6 · The paper itself

Abstract

objectivesThe purpose of this study was to assess the effect of scar tissue composition on engraftment of progenitor cells into infarcted myocardium.

backgroundScar tissue formation after myocardial infarction creates a barrier that severely compromises tissue regeneration, limiting potential functional recovery.

methodsIn vitro: A tricell patch (Tri-P) was created from peritoneum seeded and cultured with induced pluripotent stem cell-derived cardiomyocytes, endothelial cells, and mouse embryonic fibroblasts. The expression of fibrosis-related molecules from mouse embryonic fibroblasts and infarcted heart was measured by Western blot and quantitative reverse transcriptase polymerase chain reaction. In vivo: A Tri-P was affixed over the entire infarcted area 7 days after myocardial infarction in mice overexpressing adenylyl cyclase 6 (AC6). Engraftment efficiency of progenitor cells in hearts of AC6 mice was compared with that of control wild-type (WT) mice using a combination of in vivo bioluminescence imaging, post-mortem ex vivo tissue analysis, and the number of green fluorescent protein-positive cells. Echocardiography of left ventricular (LV) function was performed weekly. Hearts were harvested for analysis 4 weeks after Tri-P application. Mouse embryonic fibroblasts were stimulated with forskolin before an anoxia/reoxygenation protocol. Fibrosis-related molecules were analyzed.

resultsIn AC6 mice, infarcted hearts treated with Tri-P showed significantly higher bioluminescence imaging intensity and numbers of green fluorescent protein-positive cells than in WT mice. LV function improved progressively in AC6 mice from weeks 2 to 4 and was associated with reduced LV fibrosis.

conclusionsApplication of a Tri-P in AC6 mice resulted in significantly higher induced pluripotent stem cell engraftment accompanied by angiomyogenesis in the infarcted area and improvement in LV function.

Indexed as

Adenylyl CyclasesAnimalsCell ProliferationCicatrixCollagenEchocardiographyFibrosisHumansHuman Umbilical Vein Endothelial CellsLuminescent MeasurementsMiceMice, TransgenicMuscle DevelopmentMyocardial InfarctionMyocardiumNeovascularization, Physiologicadenylyl cyclase 6Adenylyl CyclasesCollagen

Identifiers

PMID22051336
PMCPMC3342759
OpenAlexW2159992421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.